A vaccine could be designed to cause the body’s own immune system to recognise and target the protein aggregates thought to underlie the symptoms of Alzheimer’s. Such approaches have been developed but all failed in high profile clinical trials. Why have these promising approaches not yet been successful?
Round up of this week’s news: First plane with no moving parts; possible treatment for Alzheimer’s disease; life expectancy declining; and new report on US climate change.
Researchers have discovered that low levels of the protein NPTX2 and a build-up of amyloid plaques in the brain may play a role in dementia.
Exciting new research has taken scientists a step closer to understanding the nature and possibility of memory manipulation, and it’s medical implications.
A recent study suggests the beginnings of Alzheimer’s disease may relate to the levels of vitamin A received in the womb.
Has an 18th century anatomist been vindicated by new research on how waste leaves the brain? Rachel David investigates.
Iona Twaddell investigates chronic traumatic encephalopathy in sport
Eleanor Magson investigates whether memories make us who we are.
Rapidly multiplying misfolded proteins undetected by the human immune system – Sophia Ho explains why prions are important in understanding diseases.
Themes from the last fortnight have been mosquito diseases, inflammation in disease and graphene …
Themes of the last fortnight have been the weather, further research into epigenetics and the many uses of 3D printing …
Why do we run for charity? Christina Clark explains how her grandmother’s illness prompted her to put on her trainers…